Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Israel / NCT07415213
Active, not recruiting Not applicable

Mapping Metabolic Organ Plasticity in Energy Adaptation

NCT07415213 · tracked via the Priya Life Science Israel tracker
Phase
Not applicable
Started
2026-02-03
Last updated
2026-02-17

Condition(s) studied

Overweight , ObesityEnergy Metabolism

Investigational drug(s) / intervention(s)

Calorie Restriction (CR)Time Restricted Eating (TRE)Resistance Training (RT)

Calorie Restriction (CR): Participants in the CR group will be asked to stay on an energy deficit of 500 Kcal/day, based on their RMR measurement. This intervention is designed to optimize the likelihood that a substantial degree of CR is achieved through a variety of nutritional and behavioural strategies. The CR intervention will be conceptualized as an intensive behavioural approach coupled with dietary modifications and daily self-monitoring of calories, designed to promote adherence to long-term CR. Each participant will be provided with an individualized CR prescription for \~25% CR from baseline ad libitum energy intake as determined by intake as determined by their personalized RMR.

Time Restricted Eating (TRE): Participants in the TRE groups will be instructed at weekly personal meetings to consume all meals between 10am to 6pm, and to avoid consumption of food or caloric drinks during the fasting period (8 h eating window with 16 h of fasting).

Resistance Training (RT): The participants who are assigned to the RT groups will perform supervised and monitored RT three times a week for a duration of 10 weeks. During the first two weeks of training, participants will be familiarized with RT exercises to ensure adoption, adherence, and correction of their technique. Additionally, intensity will increase from 40-60% 1-repetition maximum (1RM). Guided training sessions will start with the evaluation of 10 RM. Participants will train for 60 minutes, 3 times a week, using a full-body workout with nine exercises for a major muscle group. The exercise sessions will last \~60 minutes and will include a five-minute warmup, followed by 50 minutes of resistance exercises, including nine upper- and lower-body exercises using weight-lifting machines. In every training session, subjects will complete between 8-12 repetitions. If subjects successfully finish three sets of 12 reps, extra weight will be added to maintain an increased intensity. The r

Study summary

Brief Summary (Plain Language)

Many people who lose weight experience a slowdown in their metabolism that is greater than expected. This response, called metabolic adaptation, makes it harder to continue losing weight or to keep weight off over time. The biological reasons for this slowdown are not fully understood.

Some organs in the body, especially the liver and kidneys, use a large amount of energy even when the body is at rest. Although these organs make up only a small portion of body weight, they account for a large share of daily energy use. Changes in the size or function of these organs may play an important role in metabolic adaptation, but this has not been well studied in humans.

The purpose of this study is to understand how different lifestyle approaches affect metabolic adaptation and the size of key metabolic organs. Specifically, the study compares three common strategies:

* resistance training without calorie restriction,
* a calorie-restricted diet, and
* time-restricted eating (eating all daily food within a limited time window).

Adults with overweight will take part in one of these approaches for 10 weeks. Before and after the study period, participants will undergo advanced measurements, including magnetic resonance imaging (MRI) scans to measure liver and kidney size, tests to measure resting metabolism, and assessments of body composition. Some participants will also undergo additional testing to measure daily energy use.

By understanding how different lifestyle strategies influence metabolism and organ size, this study aims to improve knowledge about why weight loss is difficult to maintain and to support the development of more personalized approaches to long-term weight management.

Eligibility

Sex
ALL
Min age
25 Years
Max age
60 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Sedentary men and women aged 25-60 years * Body mass index (BMI) of 25-35 kg/m² Exclusion Criteria: * Participation in another exercise or weight loss program in the last 6 months * Non-stable weight (\>±5%) over the past 6 months * Smoking within the past 6 months * Post-menopause * Breastfeeding * Pregnancy or having been pregnant within the past 6 months * Contraindication for MRI scans (e.g., tattoos, intrauterine devices, permanent makeup, etc.) * Severe cardiopulmonary disease (e.g., recent myocardial infarction or unstable angina) * Musculoskeletal or neuromuscular impairments that preclude exercise training * Cognitive impairments * Other health issues, including cancer, diabetes, thyroid disease, hypertension, or chronic renal failure * Use of drugs that affect body metabolism * Secondary liver disease (viral, autoimmune, alcoholic, or hepatotoxic) * Alcohol consumption above 20 g/day for women or 30 g/day for men

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Sylvan Adams Sport Institute Tel Aviv Israel

More Tel Aviv University trials in Israel

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07415213 on ClinicalTrials.gov ↗ ← All trials in Israel